• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Yaqrit

News headline image
Yaqrit announces Liver International publication of YAQ001 microbiome data in cirrhosis, supporting its development in serious liver and gut disorders
Today 8:06 EDT
From Yaqrit
Via GlobeNewswire
News headline image
First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure
July 13, 2026
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
April 17, 2026
From Yaqrit
Via GlobeNewswire
News headline image
First patient dosed in a proof-of-concept study of Yaqrit’s advanced microbiome therapeutic YAQ001 in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
November 12, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
May 14, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL
May 07, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th
April 28, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
March 21, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
February 21, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
February 11, 2025
From Yaqrit
Via GlobeNewswire
News headline image
Yaqrit appoints new CEO Troels Jordansen to implement late clinical development and commercial strategy
January 10, 2025
From Yaqrit
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap